Alliance for Clinical Trials in Oncology
- Country
- πΊπΈUnited States
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 251
- Market Cap
- -
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-06-28
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 223
- Registration Number
- NCT00028574
- Locations
- πΊπΈ
Mobile Infirmary Medical Center, Mobile, Alabama, United States
πΊπΈEureka Community Hospital, Eureka, Illinois, United States
πΊπΈGraham Hospital, Canton, Illinois, United States
Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
- Conditions
- Prostate Cancer
- Interventions
- Drug: LHRH agonistDrug: antiandrogenRadiation: radiation therapyRadiation: Brachytherapy boost
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-07-18
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 63
- Registration Number
- NCT00006359
- Locations
- πΊπΈ
Hudner Oncology Center at Saint Anne's Hospital, Fall River, Massachusetts, United States
πΊπΈVeterans Affairs Medical Center - Syracuse, Syracuse, New York, United States
πΊπΈFlorida Hospital Cancer Institute at Florida Hospital Orlando, Orlando, Florida, United States
Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2019-10-08
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 92
- Registration Number
- NCT00003612
- Locations
- πΊπΈ
CCOP - Scottsdale Oncology Program, Scottsdale, Arizona, United States
πΊπΈCentraCare Health Plaza, Saint Cloud, Minnesota, United States
πΊπΈMedcenter One Health System, Bismarck, North Dakota, United States
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
- Conditions
- Adult Anaplastic OligodendrogliomaRecurrent Adult Brain NeoplasmAdult Mixed GliomaAdult Oligodendroglioma
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2019-10-21
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 64
- Registration Number
- NCT00049127
- Locations
- πΊπΈ
Illinois CancerCare Galesburg, Galesburg, Illinois, United States
πΊπΈMason District Hospital, Havana, Illinois, United States
πΊπΈMcdonough District Hospital, Macomb, Illinois, United States
Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2017-01-11
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 39
- Registration Number
- NCT00045591
- Locations
- πΊπΈ
University of Chicago Cancer Research Center, Chicago, Illinois, United States
πΊπΈCedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center, Los Angeles, California, United States
πΊπΈMemorial Regional Cancer Center at Memorial Regional Hospital, Hollywood, Florida, United States
Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 30
- Registration Number
- NCT00031980
- Locations
- πΊπΈ
Roswell Park Cancer Institute, Buffalo, New York, United States
Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery
- Conditions
- Lung Cancer
- Interventions
- Other: immunohistochemistry staining methodProcedure: biopsyProcedure: surgery
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2017-02-16
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 1310
- Registration Number
- NCT00003901
- Locations
- πΊπΈ
Long Island Cancer Center at Stony Brook University Hospital, Stony Brook, New York, United States
πΊπΈUSC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
πΊπΈProvidence Cancer Center, Mobile, Alabama, United States
Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)
- Conditions
- AnorexiaCachexiaFatigueLung Cancer
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-12-07
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 67
- Registration Number
- NCT00040885
- Locations
- πΊπΈ
Hope Cancer Care Center at Longmont United Hospital, Longmont, Colorado, United States
πΊπΈSt. Mary-Corwin Regional Medical Center, Pueblo, Colorado, United States
πΊπΈMason District Hospital, Havana, Illinois, United States
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Conditions
- Lung Cancer
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-12-07
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 157
- Registration Number
- NCT00022646
- Locations
- πΊπΈ
CCOP - Carle Cancer Center, Urbana, Illinois, United States
πΊπΈCentraCare Health Plaza, Saint Cloud, Minnesota, United States
πΊπΈMayo Clinic, Jacksonville, Florida, United States
Irinotecan or Fluorouracil Plus Leucovorin in Treating Patients With Previously Treated Metastatic Colorectal Cancer
- Conditions
- Colorectal Cancer
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-12-07
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 19
- Registration Number
- NCT00016952
- Locations
- π¨π¦
Allan Blair Cancer Centre, Regina, Saskatchewan, Canada
πΊπΈSiouxland Hematology-Oncology, Sioux City, Iowa, United States
πΊπΈCCOP - Wichita, Wichita, Kansas, United States